Home › Funds › Geneos Wealth Management Inc. › IXUS
Geneos Wealth Management Inc. position in IXUS
ISHARES CORE
Geneos Wealth Management Inc. reported holding 446,205 shares of IXUS (ISHARES CORE) in its Q3 2026 13F filing — a position valued at US$42.4M, representing 0.80% of its reported portfolio and ranking #18 among its reported holdings. Geneos Wealth Management Inc. has disclosed IXUS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Geneos Wealth Management Inc.'s IXUS position evolved
Geneos Wealth Management Inc. first disclosed a stake in IXUS in Q3 2023 at 411,158 shares (US$24.7M). The position peaked in Q2 2026 at 463,174 shares, worth US$44.2M. Across 13 filings, Geneos Wealth Management Inc. increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 446,205 shares valued at US$42.4M — a reduction of -16,969 shares quarter over quarter.. Notable position changes include a 34% trim in Q4 2023 (shares rose 5% over the following quarter), a 53% increase in Q2 2025 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 411.16K | $24.67M | New |
| Q4 2023 | 271.36K | $17.62M | Reduce |
| Q1 2024 | 295.36K | $20.04M | Add |
| Q2 2024 | 294.53K | $19.90M | Hold |
| Q3 2024 | 296.75K | $21.55M | Add |
| Q4 2024 | 309.49K | $20.47M | Add |
| Q1 2025 | 306.85K | $21.42M | Reduce |
| Q2 2025 | 470.98K | $36.41M | Add |
| Q3 2025 | 483.51K | $39.93M | Add |
| Q4 2025 | 475.26K | $40.23M | Reduce |
| Q1 2026 | 463.07K | $40.12M | Reduce |
| Q2 2026 | 463.17K | $44.21M | Hold |
| Q3 2026 | 446.20K | $42.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IXUS and 13F data
IXUS (ISHARES CORE) is a company whose sector is not yet classified in our data. 35 other funds we track also report a position in IXUS — the largest reported positions include BlackRock Inc (US$26.16B), Acorns Advisers, LLC (US$3.56B), ALLIANCEBERNSTEIN L.P. (US$2.23B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IXUS
- BlackRock Inc 274.12M sh · $26.16B · Q2 2026
- Acorns Advisers, LLC 37.33M sh · $3.56B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 25.79M sh · $2.23B · Q2 2026
- US BANCORP \DE\ 11.67M sh · $1.11B · Q3 2026
- CAPTRUST FINANCIAL ADVISORS 10.72M sh · $1.02B · Q3 2026
- D.A. DAVIDSON & CO. 8.09M sh · $768.09M · Q3 2026
- Focus Partners Wealth 6.90M sh · $654.12M · Q3 2026
- Sequoia Financial Advisors, LLC 6.30M sh · $600.97M · Q2 2026
- Pathstone Holdings, LLC 5.39M sh · $514.36M · Q2 2026
- Mill Creek Capital Advisors, LLC 5.36M sh · $464.17M · Q1 2026
- ADVENTIST HEALTH SYSTEM SUNBELT HEALTHCARE CORP 3.28M sh · $311.71M · Q3 2026
- AMICA MUTUAL INSURANCE CO 3.08M sh · $292.94M · Q3 2026
More on Geneos Wealth Management Inc.
FAQ
How long has Geneos Wealth Management Inc. held IXUS?
Geneos Wealth Management Inc. has disclosed IXUS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Geneos Wealth Management Inc.'s current position in IXUS?
As of Q3 2026, Geneos Wealth Management Inc. holds 446.20K shares of IXUS (ISHARES CORE), valued at $42.39M, representing 0.80% of its reported portfolio and ranking #18.
Has Geneos Wealth Management Inc. been buying or selling IXUS?
In the latest 13F filing (Q3 2026), Geneos Wealth Management Inc. reduced its position in IXUS. The position peaked in Q2 2026 at 463.17K shares.
Which other funds hold IXUS?
Other major institutional holders of IXUS include BlackRock Inc, Acorns Advisers, LLC, ALLIANCEBERNSTEIN L.P., among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.